IBBQ holdings
All 256 positions of Invesco Nasdaq Biotechnology ETF.
Positions
256
Top 10 weight
46.1%
Effective holdings
29.1
1 / sum of squared weights
In stocks
94.9%
In bonds
0.0%
Outside the US
1.8%
Asset mix
Sectors
100% of stocks classifiedCountries
Holdings
| # | Holding | Type | Weight | Value | Shares / par | Country |
|---|---|---|---|---|---|---|
| 1 | GILDGilead Sciences Inc | Equity | 8.42% | $9.1M | 61,948 | US |
| 2 | AMGNAmgen Inc | Equity | 7.94% | $8.6M | 21,107 | US |
| 3 | VRTXVertex Pharmaceuticals Inc | Equity | 7.74% | $8.4M | 16,661 | US |
| 4 | MRNAModerna, Inc. Common Stock | Equity | 5.39% | $5.8M | 29,630 | US |
| 5 | REGNRegeneron Pharmaceuticals Inc | Equity | 5.12% | $5.5M | 7,498 | US |
| 6 | RVMDRevolution Medicines, Inc. Common Stock | Equity | 2.76% | $3.0M | 15,898 | US |
| 7 | ILMNIllumina Inc | Equity | 2.74% | $3.0M | 11,210 | US |
| 8 | BIIBBiogen Inc. Common Stock | Equity | 2.21% | $2.4M | 10,967 | US |
| 9 | ALNYAlnylam Pharmaceuticals, Inc. | Equity | 2.06% | $2.2M | 9,933 | US |
| 10 | RPRXRoyalty Pharma plc Class A Ordinary Shares | Equity | 1.72% | $1.9M | 33,047 | |
| 11 | ROIVRoivant Sciences Ltd. Common Shares | Equity | 1.69% | $1.8M | 53,587 | |
| 12 | UTHRUnited Therapeutics Corp | Equity | 1.57% | $1.7M | 3,187 | US |
| 13 | INCYIncyte Genomics Inc | Equity | 1.57% | $1.7M | 15,048 | US |
| 14 | ARGXargenx SE American Depositary Shares | Cash | 1.52% | $1.7M | 2,016 | |
| 15 | GHGuardant Health, Inc. Common Stock | Equity | 1.52% | $1.6M | 9,958 | US |
| 16 | INSMInsmed, Inc. | Equity | 1.50% | $1.6M | 16,202 | US |
| 17 | VTRSViatris Inc. Common Stock | Equity | 1.37% | $1.5M | 85,214 | US |
| 18 | MEDPMedpace Holdings, Inc. Common Stock | Equity | 1.15% | $1.2M | 2,059 | US |
| 19 | EXELExelixis Inc | Equity | 1.00% | $1.1M | 18,375 | US |
| 20 | JAZZJazz Pharmaceuticals, Inc. | Equity | 0.99% | $1.1M | 4,817 | |
| 21 | NBIXNeurocrine Biosciences Inc | Equity | 0.98% | $1.1M | 7,535 | US |
| 22 | SMMTSummit Therapeutics Inc. Common Stock | Equity | 0.94% | $1.0M | 59,182 | US |
| 23 | ASNDAscendis Pharma A/S Ordinary Share | Equity | 0.94% | $1.0M | 4,562 | DK |
| 24 | BBIOBridgeBio Pharma, Inc. Common Stock | Equity | 0.89% | $967K | 14,863 | US |
| 25 | ONCBeOne Medicines Ltd. American Depositary Shares | Cash | 0.86% | $929K | 2,654 | |
| 26 | HALOHalozyme Therapeutics, Inc. | Equity | 0.85% | $924K | 8,412 | US |
| 27 | TEMTempus AI, Inc. Class A Common Stock | Equity | 0.83% | $901K | 13,005 | US |
| 28 | MDGLMadrigal Pharmaceuticals, Inc. Common Stock | Equity | 0.75% | $814K | 1,706 | US |
| 29 | BNTXBioNTech SE American Depositary Share | Cash | 0.73% | $792K | 8,603 | DE |
| 30 | BMRNBioMarin Pharmaceuticals Inc | Equity | 0.73% | $789K | 14,376 | US |
| 31 | IBRXImmunityBio, Inc. Common Stock | Equity | 0.72% | $778K | 78,542 | US |
| 32 | TWSTTwist Bioscience Corporation Common Stock | Equity | 0.69% | $747K | 4,913 | US |
| 33 | KRYSKrystal Biotech, Inc. Common Stock | Equity | 0.67% | $721K | 2,203 | US |
| 34 | PCVXVaxcyte, Inc. Common Stock | Equity | 0.66% | $717K | 11,025 | US |
| 35 | TXG10x Genomics, Inc. Class A Common Stock | Equity | 0.64% | $690K | 8,930 | US |
| 36 | KYMRKymera Therapeutics, Inc. Common Stock | Equity | 0.62% | $673K | 6,160 | US |
| 37 | PTGXProtagonist Therapeutics, Inc | Equity | 0.62% | $672K | 4,804 | US |
| 38 | AXSMAxsome Therapeutics, Inc | Equity | 0.61% | $660K | 3,882 | US |
| 39 | SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share) | Cash | 0.59% | $644K | 16,006 | FR |
| 40 | CYTKCytokinetics Inc. | Equity | 0.59% | $639K | 10,311 | US |
| 41 | ARWRArrowhead Research Corporation | Equity | 0.59% | $638K | 10,498 | US |
| 42 | CAICaris Life Sciences, Inc. Common Stock | Equity | 0.53% | $576K | 20,957 | US |
| 43 | PRAXPraxis Precision Medicines, Inc. Common Stock | Equity | 0.50% | $543K | 2,059 | US |
| 44 | IONSIonis Pharmaceuticals, Inc. Common Stock | Equity | 0.49% | $533K | 12,314 | US |
| 45 | SYRESpyre Therapeutics, Inc. Common Stock | Equity | 0.48% | $521K | 6,526 | US |
| 46 | AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock | Equity | 0.47% | $507K | 25,824 | US |
| 47 | ALKSAlkermes Inc. plc | Equity | 0.46% | $500K | 12,457 | |
| 48 | IMVTImmunovant, Inc. Common Stock | Equity | 0.43% | $464K | 15,339 | US |
| 49 | RYTMRhythm Pharmaceuticals, Inc. Common Stock | Equity | 0.42% | $458K | 5,113 | US |
| 50 | IOVAIovance Biotherapeutics, Inc. Common Stock | Equity | 0.41% | $447K | 33,583 | US |
| 51 | LGNDLigand Pharmaceuticals Inc. | Equity | 0.41% | $442K | 1,497 | US |
| 52 | GRALGRAIL, Inc. Common Stock | Equity | 0.40% | $438K | 3,300 | US |
| 53 | KODKodiak Sciences Inc Common Stock | Equity | 0.40% | $437K | 4,633 | US |
| 54 | CGONCG Oncology, Inc. Common stock | Equity | 0.38% | $415K | 6,556 | US |
| 55 | ERASErasca, Inc. Common Stock | Equity | 0.37% | $401K | 25,962 | US |
| 56 | MIRMMirum Pharmaceuticals, Inc. Common Stock | Equity | 0.36% | $392K | 4,818 | US |
| 57 | COGTCogent Biosciences, Inc. Common Stock | Equity | 0.36% | $387K | 12,872 | US |
| 58 | PTCTPTC Therapeutics, Inc. | Equity | 0.36% | $386K | 6,176 | US |
| 59 | SRRKScholar Rock Holding Corporation Common Stock | Equity | 0.35% | $381K | 9,031 | US |
| 60 | ORKAOruka Therapeutics, Inc. Common Stock | Equity | 0.35% | $379K | 4,900 | US |
| 61 | ABVXAbivax SA American Depositary Shares | Cash | 0.35% | $377K | 4,233 | FR |
| 62 | TVTXTravere Therapeutics, Inc. Common Stock | Equity | 0.34% | $364K | 7,004 | US |
| 63 | CRSPCRISPR Therapeutics AG | Equity | 0.33% | $361K | 7,160 | US |
| 64 | DFTXDefinium Therapeutics, Inc. Common Shares | Equity | 0.31% | $341K | 9,969 | |
| 65 | EWTXEdgewise Therapeutics, Inc. Common Stock | Equity | 0.29% | $316K | 8,047 | US |
| 66 | INDVIndivior Pharmaceuticals, Inc. Common Stock | Equity | 0.29% | $310K | 8,745 | US |
| 67 | ADPTAdaptive Biotechnologies Corporation Common Stock | Equity | 0.29% | $309K | 11,848 | US |
| 68 | ABCLAbCellera Biologics Inc. Common Shares | Equity | 0.27% | $289K | 24,051 | CA |
| 69 | RLAYRelay Therapeutics, Inc. Common Stock | Equity | 0.26% | $283K | 16,233 | US |
| 70 | TNGXTango Therapeutics, Inc. | Equity | 0.26% | $282K | 12,513 | US |
| 71 | KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares | Equity | 0.26% | $282K | 3,576 | GB |
| 72 | VCYTVeracyte, Inc. | Equity | 0.24% | $261K | 5,988 | US |
| 73 | XENEXenon Pharmaceuticals Inc | Equity | 0.24% | $259K | 7,169 | |
| 74 | GMABGenmab A/S ADS | Cash | 0.24% | $259K | 7,177 | DK |
| 75 | IDYAIDEAYA Biosciences, Inc. Common Stock | Equity | 0.24% | $258K | 7,147 | US |
| 76 | AMLXAmylyx Pharmaceuticals, Inc. Common Stock | Equity | 0.23% | $253K | 9,314 | US |
| 77 | ACADAcadia Pharmaceuticals Inc. | Equity | 0.23% | $250K | 12,781 | US |
| 78 | TARSTarsus Pharmaceuticals, Inc. Common Stock | Equity | 0.23% | $248K | 3,429 | US |
| 79 | ARQTArcutis Biotherapeutics, Inc. Common Stock | Equity | 0.21% | $228K | 9,314 | US |
| 80 | DYNDyne Therapeutics, Inc. Common Stock | Equity | 0.21% | $227K | 13,851 | US |
| 81 | DNLIDenali Therapeutics Inc. Common Stock | Equity | 0.20% | $222K | 11,877 | US |
| 82 | ELVNEnliven Therapeutics, Inc. Common Stock | Equity | 0.20% | $221K | 5,440 | US |
| 83 | PGENPrecigen, Inc. Common Stock | Equity | 0.19% | $201K | 26,495 | US |
| 84 | MBXMBX Biosciences, Inc. Common Stock | Equity | 0.17% | $189K | 3,557 | US |
| 85 | NAMSNewAmsterdam Pharma Company N.V. Ordinary Shares | Equity | 0.17% | $189K | 8,887 | |
| 86 | BEAMBeam Therapeutics Inc. Common Stock | Equity | 0.17% | $188K | 7,659 | US |
| 87 | SUPNSupernus Pharmaceuticals, Inc. | Equity | 0.17% | $181K | 4,294 | US |
| 88 | IRONDisc Medicine, Inc. Common Stock | Equity | 0.16% | $174K | 2,863 | US |
| 89 | ADMAADMA Biologics, Inc. | Equity | 0.16% | $172K | 16,632 | US |
| 90 | HRMYHarmony Biosciences Holdings, Inc. Common Stock | Equity | 0.16% | $171K | 4,315 | US |
| 91 | NRIXNurix Therapeutics, Inc. Common stock | Equity | 0.16% | $171K | 7,693 | US |
| 92 | PHVSPharvaris N.V. Ordinary Shares | Equity | 0.15% | $162K | 5,213 | NL |
| 93 | AUPHAurinia Pharmaceuticals Inc | Equity | 0.15% | $160K | 9,884 | |
| 94 | VERAVera Therapeutics, Inc. Class A Common Stock | Equity | 0.15% | $159K | 5,363 | US |
| 95 | BCRXBioCryst Pharmaceuticals Inc | Equity | 0.15% | $158K | 19,004 | US |
| 96 | RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock | Equity | 0.14% | $157K | 39,694 | US |
| 97 | GPCRStructure Therapeutics Inc. American Depositary Shares | Cash | 0.14% | $156K | 6,085 | |
| 98 | VCELVericel Corporation | Equity | 0.14% | $152K | 3,800 | US |
| 99 | MLYSMineralys Therapeutics, Inc. Common Stock | Equity | 0.14% | $146K | 6,541 | US |
| 100 | FTREFortrea Holdings Inc. Common Stock | Equity | 0.13% | $144K | 7,076 | US |
| 101 | SRPTSarepta Therapeutics,, Inc. Common Stock | Equity | 0.13% | $142K | 7,820 | US |
| 102 | ALVOAlvotech Ordinary Shares | Equity | 0.13% | $142K | 25,091 | |
| 103 | AGIOAgios Pharmaceuticals, Inc. | Equity | 0.13% | $141K | 4,429 | US |
| 104 | VIRVir Biotechnology, Inc. Common Stock | Equity | 0.13% | $140K | 12,604 | US |
| 105 | XERSXeris Biopharma Holdings, Inc. Common Stock | Equity | 0.13% | $138K | 13,523 | US |
| 106 | TRVITrevi Therapeutics, Inc. Common Stock | Equity | 0.12% | $135K | 10,553 | US |
| 107 | NVAXNovavax Inc | Equity | 0.12% | $135K | 12,288 | US |
| 108 | XNCRXencor, Inc. | Equity | 0.12% | $135K | 5,492 | US |
| 109 | URGNUroGen Pharma Ltd. Ordinary Shares | Equity | 0.12% | $134K | 3,627 | US |
| 110 | ZYMEZymeworks Inc. | Equity | 0.12% | $133K | 5,248 | US |
| 111 | NTLAIntellia Therapeutics, Inc | Equity | 0.12% | $131K | 10,427 | US |
| 112 | SEPNSepterna, Inc. Common Stock | Equity | 0.12% | $128K | 3,473 | US |
| 113 | LEGNLegend Biotech Corporation American Depositary Shares | Cash | 0.12% | $128K | 6,822 | |
| 114 | PSNLPersonalis, Inc. Common Stock | Equity | 0.12% | $128K | 7,939 | US |
| 115 | ZBIOZenas BioPharma, Inc. Common Stock | Equity | 0.12% | $127K | 4,834 | US |
| 116 | NVCRNovoCure Limited Ordinary Shares | Equity | 0.11% | $123K | 8,667 | |
| 117 | OCULOcular Therapeutix, Inc. | Equity | 0.11% | $122K | 16,236 | US |
| 118 | ANIPANI Pharmaceuticals, Inc. | Equity | 0.11% | $121K | 1,686 | US |
| 119 | ETONEton Pharmaceutcials, Inc. Common Stock | Equity | 0.11% | $117K | 2,138 | US |
| 120 | QUREuniQure N.V. | Equity | 0.11% | $116K | 5,146 | |
| 121 | STOKStoke Therapeutics, Inc. Common Stock | Equity | 0.11% | $115K | 4,792 | US |
| 122 | CMPSCOMPASS Pathways Plc American Depository Shares | Cash | 0.11% | $114K | 9,958 | GB |
| 123 | ABSIAbsci Corporation Common Stock | Equity | 0.11% | $114K | 12,750 | US |
| 124 | SNDXSyndax Pharmaceuticals, Inc. | Equity | 0.10% | $112K | 6,644 | US |
| 125 | INVAInnoviva, Inc. Common Stock | Equity | 0.10% | $112K | 5,374 | US |
| 126 | RAREUltragenyx Pharmaceutical Inc. | Equity | 0.10% | $112K | 7,301 | US |
| 127 | PCRXPacira BioSciences, Inc. Common Stock | Equity | 0.10% | $107K | 2,944 | US |
| 128 | TSHATaysha Gene Therapies, Inc. Common Stock | Equity | 0.10% | $107K | 24,166 | US |
| 129 | MAZEMaze Therapeutics, Inc. Common Stock | Equity | 0.10% | $106K | 4,113 | US |
| 130 | RAPPRapport Therapeutics, Inc. Common Stock | Equity | 0.10% | $106K | 3,547 | US |
| 131 | GHRSGH Research PLC Ordinary Shares | Equity | 0.10% | $104K | 5,099 | IE |
| 132 | OMEROmeros Corporation | Equity | 0.10% | $103K | 5,385 | US |
| 133 | ANABAnaptysBio, Inc. Common Stock | Equity | 0.09% | $102K | 2,208 | US |
| 134 | IMCRImmunocore Holdings plc American Depositary Shares | Cash | 0.09% | $100K | 3,451 | GB |
| 135 | INBXInhibrx Biosciences, Inc. Common Stock | Equity | 0.09% | $100K | 1,081 | US |
| 136 | ORICOric Pharmaceuticals, Inc. Common Stock | Equity | 0.09% | $92K | 7,675 | US |
| 137 | REPLReplimune Group, Inc. | Equity | 0.08% | $91K | 7,002 | US |
| 138 | TYRATyra Biosciences, Inc. Common Stock | Equity | 0.08% | $88K | 4,424 | US |
| 139 | HROWHarrow, Inc. Common Stock | Equity | 0.08% | $85K | 2,797 | US |
| 140 | BCAXBicara Therapeutics Inc. Common Stock | Equity | 0.08% | $85K | 4,901 | US |
| 141 | TRAXFirst Tracks Biotherapeutics, Inc. Ordinary Shares | Equity | 0.08% | $85K | 2,640 | US |
| 142 | JANXJanux Therapeutics, Inc. Common Stock | Equity | 0.08% | $84K | 4,560 | US |
| 143 | VORVor Biopharma Inc. Common Stock | Equity | 0.08% | $84K | 4,405 | US |
| 144 | ZLABZai Lab Limited American Depositary Shares | Cash | 0.08% | $82K | 3,294 | |
| 145 | AMPHAmphastar Pharmaceuticals, Inc. | Equity | 0.08% | $82K | 3,164 | US |
| 146 | MNKDMannkind Corporation | Equity | 0.08% | $82K | 23,847 | US |
| 147 | MRVIMaravai LifeSciences Holdings, Inc. Class A Common Stock | Equity | 0.07% | $80K | 11,056 | US |
| 148 | CSTLCastle Biosciences, Inc. Common Stock | Equity | 0.07% | $77K | 2,277 | US |
| 149 | MGTXMeiraGTx Holdings plc Ordinary Shares | Equity | 0.07% | $75K | 7,118 | US |
| 150 | SVRASavara Inc. | Equity | 0.07% | $74K | 15,381 | US |
| 151 | CGEMCullinan Therapeutics, Inc. Common Stock | Equity | 0.07% | $74K | 4,781 | US |
| 152 | KURAKura Oncology, Inc. | Equity | 0.06% | $70K | 6,655 | US |
| 153 | ALMSAlumis Inc. Common Stock | Equity | 0.06% | $67K | 9,609 | US |
| 154 | GRFSGrifois, S.A. | Cash | 0.06% | $67K | 9,011 | ES |
| 155 | RIGLRigel Pharmaceuticals Inc. (New) | Equity | 0.06% | $67K | 1,369 | US |
| 156 | GLUEMonte Rosa Therapeutics, Inc. Common Stock | Equity | 0.06% | $65K | 6,334 | US |
| 157 | CRVSCorvus Pharmaceuticals, Inc. | Equity | 0.06% | $64K | 6,310 | US |
| 158 | SANASana Biotechnology, Inc. Common Stock | Equity | 0.06% | $62K | 22,207 | US |
| 159 | ABUSArbutus Biopharma Corporation Common Stock | Equity | 0.06% | $62K | 14,814 | |
| 160 | AVBPArriVent BioPharma, Inc. Common Stock | Equity | 0.06% | $61K | 3,642 | US |
| 161 | ARDXArdelyx, Inc. | Equity | 0.06% | $61K | 18,607 | US |
| 162 | PAHCPhibro Animal Health Corporation Class A | Equity | 0.05% | $59K | 1,572 | US |
| 163 | GERNGeron Corp | Equity | 0.05% | $58K | 47,306 | US |
| 164 | ANNXAnnexon, Inc. Common Stock | Equity | 0.05% | $56K | 14,076 | US |
| 165 | CADLCandel Therapeutics, Inc. Common Stock | Equity | 0.05% | $55K | 5,692 | US |
| 166 | SLDBSolid Biosciences Inc. Common Stock | Equity | 0.05% | $54K | 7,967 | US |
| 167 | COLLCollegium Pharmaceutical, Inc. Common Stock | Equity | 0.05% | $54K | 2,446 | US |
| 168 | DSGNDesign Therapeutics, Inc. Common Stock | Equity | 0.05% | $54K | 4,698 | US |
| 169 | MESOMesoblast Limited American Depositary Shares | Cash | 0.05% | $54K | 3,924 | AU |
| 170 | PACBPacific Biosciences of California, Inc. | Equity | 0.05% | $53K | 23,073 | US |
| 171 | FDMT4D Molecular Therapeutics, Inc. Common Stock | Equity | 0.05% | $51K | 4,049 | US |
| 172 | OABIOmniAb, Inc. Common Stock | Equity | 0.05% | $51K | 10,855 | US |
| 173 | OLMAOlema Pharmaceuticals, Inc. Common Stock | Equity | 0.05% | $50K | 6,445 | US |
| 174 | WVEWave Life Sciences Ltd. Ordinary Shares | Equity | 0.05% | $50K | 14,463 | |
| 175 | AURAAura Biosciences, Inc. Common Stock | Equity | 0.05% | $50K | 7,697 | US |
| 176 | ZVRAZevra Therapeutics, Inc. Common Stock | Equity | 0.04% | $49K | 4,419 | US |
| 177 | PRMEPrime Medicine, Inc. Common Stock | Equity | 0.04% | $48K | 13,463 | US |
| 178 | IRWDIronwood Pharmaceuticals, Inc. - Class A | Equity | 0.04% | $47K | 12,254 | US |
| 179 | AGPXXInvesco Government & Agency Portfolio | Cash | 0.04% | $47K | 47,299 | |
| 180 | AQSTAquestive Therapeutics, Inc. Common Stock | Equity | 0.04% | $45K | 9,415 | US |
| 181 | PHATPhathom Pharmaceuticals, Inc. Common Stock | Equity | 0.04% | $43K | 6,027 | US |
| 182 | CRMDCorMedix Inc. | Equity | 0.04% | $42K | 5,783 | US |
| 183 | ACRSAclaris Therapeutics, Inc. | Equity | 0.04% | $41K | 10,922 | US |
| 184 | SGMTSagimet Biosciences Inc. Series A Common Stock | Equity | 0.04% | $41K | 4,582 | US |
| 185 | NGNENeurogene, Inc. Common Stock | Equity | 0.04% | $40K | 1,501 | US |
| 186 | CTMXCytomX Therapeutics, Inc. | Equity | 0.04% | $40K | 16,015 | US |
| 187 | RGNXREGENXBIO Inc. | Equity | 0.04% | $40K | 4,887 | US |
| 188 | EOLSEvolus, Inc. Common Stock | Equity | 0.04% | $38K | 4,935 | US |
| 189 | PBYIPUMA BIOTECHNOLOGY INC | Equity | 0.04% | $38K | 3,820 | US |
| 190 | ALTAltimmune, Inc. Common Stock | Equity | 0.03% | $38K | 14,437 | US |
| 191 | ARVNArvinas, Inc | Equity | 0.03% | $37K | 4,862 | US |
| 192 | ALLOAllogene Therapeutics, Inc. Common Stock | Equity | 0.03% | $36K | 25,645 | US |
| 193 | KMDAKamada Ltd | Equity | 0.03% | $34K | 4,375 | IL |
| 194 | LKFTLakefront Biotherapeutics American Depositary Shares | Cash | 0.03% | $34K | 1,150 | BE |
| 195 | SLNSilence Therapeutics Plc American Depository Share | Cash | 0.03% | $34K | 3,538 | GB |
| 196 | SPRYARS Pharmaceuticals, Inc. Common Stock | Equity | 0.03% | $34K | 7,380 | US |
| 197 | TKNOAlpha Teknova, Inc. Common Stock | Equity | 0.03% | $33K | 3,966 | US |
| 198 | EDITEditas Medicine, Inc. Common Stock | Equity | 0.03% | $33K | 11,616 | US |
| 199 | PRTAProthena Corporation plc Ordinary Shares | Equity | 0.03% | $33K | 3,816 | |
| 200 | CTNMContineum Therapeutics, Inc. Class A Common Stock | Equity | 0.03% | $32K | 2,464 | US |
| 201 | TECXTectonic Therapeutic, Inc. Common Stock | Equity | 0.03% | $32K | 1,399 | US |
| 202 | AVIRAtea Pharmaceuticals, Inc. Common Stock | Equity | 0.03% | $31K | 6,057 | US |
| 203 | KYTXKyverna Therapeutics, Inc. Common Stock | Equity | 0.03% | $28K | 4,589 | US |
| 204 | ARCTArcturus Therapeutics Holdings Inc. Common Stock | Equity | 0.03% | $28K | 2,144 | US |
| 205 | AUTLAutolus Therapeutics plc American Depositary Share | Cash | 0.02% | $26K | 14,870 | GB |
| 206 | ENTAEnanta Pharmaceuticals, Inc | Equity | 0.02% | $26K | 2,173 | US |
| 207 | CCCCC4 Therapeutics, Inc. | Equity | 0.02% | $26K | 9,110 | US |
| 208 | OBIOOrchestra BioMed Holdings, Inc. Ordinary Shares | Equity | 0.02% | $26K | 4,465 | US |
| 209 | CABACabaletta Bio, Inc. Common Stock | Equity | 0.02% | $24K | 12,268 | US |
| 210 | EYPTEyePoint, Inc. Common Stock | Equity | 0.02% | $22K | 6,252 | US |
| 211 | BIOABioAge Labs, Inc. Common Stock | Equity | 0.02% | $22K | 3,477 | US |
| 212 | RCKTRocket Pharmaceuticals, Inc. Common Stock | Equity | 0.02% | $21K | 8,130 | US |
| 213 | FULCFulcrum Therapeutics, Inc. Common Stock | Equity | 0.02% | $21K | 5,678 | US |
| 214 | LRMRLarimar Therapeutics, Inc. Common Stock | Equity | 0.02% | $21K | 7,708 | US |
| 215 | VNDAVanda Pharmaceuticals Inc. | Equity | 0.02% | $20K | 4,488 | US |
| 216 | LXEOLexeo Therapeutics, Inc. Common Stock | Equity | 0.02% | $19K | 5,996 | US |
| 217 | ACIUAC Immune SA | Equity | 0.02% | $19K | 7,529 | CH |
| 218 | UPBUpstream Bio, Inc. Common Stock | Equity | 0.02% | $19K | 4,079 | US |
| 219 | IMRXImmuneering Corporation Class A Common Stock | Equity | 0.02% | $18K | 4,803 | US |
| 220 | LFCRLifecore Biomedical, Inc. Common Stock | Equity | 0.02% | $18K | 2,790 | US |
| 221 | QSIQuantum-Si Incorporated Class A Common Stock | Equity | 0.02% | $18K | 14,482 | US |
| 222 | SIGASIGA Technologies Inc. | Equity | 0.02% | $18K | 5,349 | US |
| 223 | KROSKeros Therapeutics, Inc. Common Stock | Equity | 0.02% | $17K | 1,499 | US |
| 224 | SIONSionna Therapeutics, Inc. Common Stock | Equity | 0.02% | $16K | 3,335 | US |
| 225 | TRDAEntrada Therapeutics, Inc. Common Stock | Equity | 0.01% | $16K | 2,889 | US |
| 226 | LYELLyell Immunopharma, Inc. Common Stock | Equity | 0.01% | $15K | 1,749 | US |
| 227 | IVVDInvivyd, Inc. Common Stock | Equity | 0.01% | $15K | 21,868 | US |
| 228 | BCYCBicycle Therapeutics plc American Depositary Shares | Cash | 0.01% | $13K | 3,451 | GB |
| 229 | PYXSPyxis Oncology, Inc. Common Stock | Equity | 0.01% | $12K | 6,177 | US |
| 230 | CHRSCoherus Oncology, Inc. Common Stock | Equity | 0.01% | $12K | 11,478 | US |
| 231 | PEPGPepGen Inc. Common Stock | Equity | 0.01% | $12K | 5,139 | US |
| 232 | MENSJyong Biotech Ltd. Ordinary Shares | Equity | 0.01% | $12K | 5,537 | TW |
| 233 | NBPNovaBridge Biosciences American Depositary Shares | Cash | 0.01% | $11K | 8,262 | |
| 234 | CDXSCodexis, Inc. | Equity | 0.01% | $11K | 8,113 | US |
| 235 | AVXLAnavex Life Sciences | Equity | 0.01% | $11K | 6,860 | US |
| 236 | VYGRVoyager Therapeutics, Inc. Common Stock | Equity | 0.01% | $11K | 4,448 | US |
| 237 | USDProShares Ultra Semiconductors | Cash | 0.01% | $9K | 9,230 | US |
| 238 | HUMAHumacyte, Inc. Common Stock | Equity | 0.01% | $9K | 20,606 | US |
| 239 | FHTXFoghorn Therapeutics Inc. Common Stock | Equity | 0.01% | $9K | 4,419 | US |
| 240 | TNYATenaya Therapeutics, Inc. Common Stock | Equity | 0.01% | $9K | 15,851 | US |
| 241 | LENZLENZ Therapeutics, Inc. Common Stock | Equity | 0.01% | $8K | 2,282 | US |
| 242 | BDTXBlack Diamond Therapeutics, Inc. Common Stock | Equity | 0.01% | $8K | 4,191 | US |
| 243 | AARDAardvark Therapeutics, Inc. Common Stock | Equity | 0.01% | $8K | 1,600 | US |
| 244 | RANIRani Therapeutics Holdings, Inc. Class A Common Stock | Equity | 0.01% | $7K | 8,269 | |
| 245 | NMRANeumora Therapeutics, Inc. Common Stock | Equity | 0.01% | $6K | 13,308 | US |
| 246 | GOSSGossamer Bio, Inc. Common Stock | Equity | 0.00% | $4K | 435 | US |
| 247 | CRBUCaribou Biosciences, Inc. Common Stock | Equity | 0.00% | $4K | 7,303 | US |
| 248 | Cartesian Therapeutics Inc | Other | 0.00% | $359 | 2,633 | US |
| 249 | Coherus Oncology Inc2050-12 | Other | 0.00% | $0 | 10,938 | US |
| 250 | Eli Lilly & Co | Other | 0.00% | $0 | 6,344 | |
| 251 | Esperion Therapeutics Inc | Other | 0.00% | $0 | 13,225 | US |
| 252 | Novo Nordisk A/S | Other | 0.00% | $0 | 3,794 | DK |
| 253 | OmniAb Inc2027-11 | Other | 0.00% | $0 | 125 | US |
| 254 | OmniAb Inc2027-11 | Other | 0.00% | $0 | 125 | US |
| 255 | SECURITIES LENDING - BNYM | Cash | 0.00% | $0 | 1 | |
| 256 | THRDThird Harmonic Bio, Inc. Common Stock | Equity | 0.00% | $0 | 1,605 | US |
Find which other funds hold a stock by opening it and choosing "ETFs holding".
Position changes between reports
| Action | Holding | Weight before | Weight after | Shares vs flows | Between reports |
|---|---|---|---|---|---|
| Decrease | GILDGilead Sciences, Inc. | 9.61% | 7.39% | −20.4% | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | AMGNAmgen Inc. | 9.12% | 7.10% | −16.1% | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | VRTXVertex Pharmaceuticals Inc. | 9.30% | 7.38% | −17.7% | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | ACLXArcellx, Inc. | 0.49% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | FOLDAmicus Therapeutics, Inc. | 0.33% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | TERNTerns Pharmaceuticals, Inc. | 0.28% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | APLSApellis Pharmaceuticals, Inc. | 0.20% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | CNTACentessa Pharmaceuticals PLC | 0.19% | 0.38% | +24.4% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | IMVTImmunovant, Inc. | 0.36% | 0.54% | +16.8% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | PRAXPraxis Precision Medicines, Inc. | 0.63% | 0.78% | +10.4% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | MIRMMirum Pharmaceuticals, Inc. | 0.36% | 0.49% | +16.3% | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | RAPTRAPT Therapeutics, Inc. | 0.12% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | DYNDyne Therapeutics, Inc. | 0.16% | 0.25% | +16.4% | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | DAWNDay One Biopharmaceuticals, Inc. | 0.08% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | KODKodiak Sciences Inc. | 0.10% | 0.18% | +16.5% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | WVEWave Life Sciences Ltd. | 0.17% | 0.10% | +13.4% | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | VTYXVentyx Biosciences, Inc. | 0.07% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | GPCRStructure Therapeutics Inc. | 0.31% | 0.24% | +17.4% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | BCRXBioCryst Pharmaceuticals, Inc. | 0.14% | 0.18% | +20.1% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | BCAXBicara Therapeutics Inc. | 0.07% | 0.11% | +15.6% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | KYMRKymera Therapeutics, Inc. | 0.49% | 0.53% | +13.1% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | BNTXBioNTech SE | 0.83% | 0.87% | +12.1% | Feb 28, 2026 → May 31, 2026 SEC |
| New position | TRAXFirst Tracks Biotherapeutics, Inc. | — | 0.03% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | PSNLPersonalis, Inc. | 0.06% | 0.09% | +17.0% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | GLUEMonte Rosa Therapeutics, Inc. | 0.09% | 0.12% | +17.3% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | ERASErasca, Inc. | 0.29% | 0.32% | +10.1% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | VORVor BioPharma Inc. | 0.02% | 0.05% | +145.4% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | CADLCandel Therapeutics, Inc. | 0.02% | 0.05% | +31.9% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | VIRVir Biotechnology, Inc. | 0.09% | 0.12% | +13.0% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | ACRSAclaris Therapeutics, Inc. | 0.02% | 0.04% | +10.6% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | CRVSCorvus Pharmaceuticals, Inc. | 0.10% | 0.08% | +11.3% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | KYTXKyverna Therapeutics, Inc. | 0.03% | 0.04% | +30.5% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | VERAVera Therapeutics, Inc. | 0.19% | 0.20% | +12.1% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | GMABGenmab A/S | 0.13% | 0.13% | +11.1% | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | ZLABZai Lab Ltd. | 0.06% | 0.05% | −12.6% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | CTNMContineum Therapeutics, Inc. | 0.03% | 0.03% | +30.6% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | PHATPhathom Pharmaceuticals, Inc. | 0.07% | 0.06% | +12.4% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | ALMSAlumis Inc. | 0.21% | 0.22% | +30.8% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | LRMRLarimar Therapeutics, Inc. | 0.03% | 0.03% | +26.3% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | ALTAltimmune, Inc. | 0.03% | 0.03% | +19.4% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | FULCFulcrum Therapeutics, Inc. | 0.03% | 0.04% | +20.9% | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | FDMT4D Molecular Therapeutics, Inc. | 0.04% | 0.04% | −11.3% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | BIOABioAge Labs, Inc. | 0.06% | 0.06% | +19.4% | Feb 28, 2026 → May 31, 2026 SEC |
Share-count changes are measured after removing what creations and redemptions explain.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.